Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012
Zahava Berkowitz(Centers for Disease Control and Prevention), Mona Saraiya(Merck & Co., Inc., Rahway, NJ, USA (United States)), Molly Malone(Emory University), Juan Rodríguez(University of Gothenburg)
Cited by 37
Related Papers
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|PsycEXTRA Dataset|2007|1.9k
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
|PubMed|2015|1.1k
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
|JNCI Journal of the National Cancer Institute|2013|997
Human Papillomavirus–Associated Cancers — United States, 2008–2012
|MMWR Morbidity and Mortality Weekly Report|2016|876
Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
|MMWR Morbidity and Mortality Weekly Report|2018|516